Overview Financials News + Filings Key Docs Charts Ownership Insiders |
U.S. GOLD CORP. (USAU)
|
Add to portfolio |
|
|
Price: |
$8.74
| | Metrics |
OS: |
9.29
|
M
| |
-39
|
% ROE
|
Market cap: |
$81.2
|
M
| |
-57
|
% ROIC
|
Net cash:
|
$5.28
|
M
| |
$0.57
|
per share
|
EV:
|
$75.9
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($9.2)
|
M
| |
|
|
EBIT
|
($9.3)
|
M
| |
|
|
EPS |
($0.92)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Apr-30-22 | Apr-30-21 | Apr-30-20 | Apr-30-19 | Apr-30-18 | Apr-30-17 | Apr-30-16 | Apr-30-15 |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 25.2 | 28.3 |
Revenue growth | | | | | | -100.0% | -10.9% | -7.0% |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 26.4 | 31.0 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.2 | -2.7 |
Gross margin | | | | | | | -4.9% | -9.7% |
Selling, general and administrative | | | | | | | 5.8 | 6.2 |
Research and development | | | | | | | | |
General and administrative | 5.4 | 5.0 | 3.0 | 2.8 | 3.2 | 1.7 | | |
EBITA | -15.0 | -12.4 | -5.5 | 0.0 | -8.2 | -4.1 | -1.0 | -2.7 |
EBITA margin | | | | | | | -4.0% | -9.7% |
Amortization of intangibles | | | 0.2 | | | | 0.0 | |
EBIT | -15.0 | -12.4 | -5.7 | 0.0 | -8.2 | -4.1 | -1.1 | -2.7 |
EBIT margin | | | | | | | -4.2% | -9.7% |
Pre-tax income | -13.9 | -12.4 | -5.7 | -7.6 | -8.3 | -4.1 | -1.4 | -3.8 |
Income taxes | 0.0 | 0.0 | -0.4 | 0.4 | -0.4 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.2% | 0.0% | 7.7% | | 5.3% | 0.0% | 0.2% | |
Earnings from continuing ops | -13.9 | -17.9 | -7.3 | -8.0 | -3.5 | -4.1 | -1.3 | -5.6 |
Earnings from discontinued ops | | | | | -11.8 | | | |
Net income | -13.9 | -17.9 | -7.3 | -8.0 | -15.2 | -4.1 | -1.3 | -5.6 |
Net margin | | | | | | | -5.3% | -19.8% |
|
Diluted EPS | ($1.92) | ($3.80) | ($3.17) | ($4.36) | ($0.26) | ($0.42) | ($4.28) | ($6.60) |
Shares outstanding (diluted) | 7.3 | 4.7 | 2.3 | 1.8 | 13.4 | 9.8 | 0.3 | 0.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|